Response to ‘Tacrolimus pharmacokinetics after kidney transplantation – Influence of changes in haematocrit and steroid dose’

類似資料

• Progressive decline in tacrolimus clearance after renal transplantation is partially explained by decreasing CYP3A4 activity and increasing haematocrit
  著者:: de Jonge, Hylke, 等
  出版事項: (2015)
• Tacrolimus pharmacokinetics after kidney transplantation – Influence of changes in haematocrit and steroid dose
  著者:: Staatz, C. E., 等
  出版事項: (2015)
• Comparative performance of oral midazolam clearance and plasma 4β‐hydroxycholesterol to explain interindividual variability in tacrolimus clearance
  著者:: Vanhove, Thomas, 等
  出版事項: (2016)
• Pretransplant 4β‐hydroxycholesterol does not predict tacrolimus exposure or dose requirements during the first days after kidney transplantation
  著者:: Vanhove, Thomas, 等
  出版事項: (2017)
• Pharmacokinetics, Pharmacodynamics and Pharmacogenetics of Tacrolimus in Kidney Transplantation
  著者:: Yu, Meng, 等
  出版事項: (2018)